Evaluation of cellular and humoral immune responses to allogeneic adipose-derived stem/stromal cells.

[1]  Mandi J. Lopez,et al.  Immunogenicity of allogeneic adipose-derived stem cells in a rat spinal fusion model. , 2009, Tissue engineering. Part A.

[2]  G. Dini,et al.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.

[3]  L. Plánka,et al.  Chondrocytic Potential of Allogenic Mesenchymal Stem Cells Transplanted without Immunosuppression to Regenerate Physeal Defect in Rabbits , 2010 .

[4]  W. Weimar,et al.  Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. , 2007, Stem cells and development.

[5]  O. Ringdén,et al.  No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients , 2007, Haematologica.

[6]  X. Chen,et al.  Survival of bone marrow‐derived mesenchymal stem cells in a xenotransplantation model , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[7]  Yilin Cao,et al.  Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. , 2007, Tissue engineering.

[8]  M. van Griensven,et al.  Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. , 2007, Tissue engineering.

[9]  R. Cancedda,et al.  Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. , 2007, Arthritis and rheumatism.

[10]  A. Poncelet,et al.  Although Pig Allogeneic Mesenchymal Stem Cells Are Not Immunogenic In Vitro, Intracardiac Injection Elicits an Immune Response In Vivo , 2007, Transplantation.

[11]  Antonio Uccelli,et al.  Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis , 2007, Annals of neurology.

[12]  N. Sasaki,et al.  Mesenchymal Stem Cells Facilitate the Induction of Mixed Hematopoietic Chimerism and Islet Allograft Tolerance without GVHD in the Rat , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  P. Kasten,et al.  Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. , 2007, Tissue engineering.

[14]  Shiqiang Yu,et al.  Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. , 2006, Transplantation proceedings.

[15]  R. Willemze,et al.  Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. , 2006, Blood.

[16]  A. Bartholomew,et al.  Immunologic Consequences of Multiple, High-Dose Administration of Allogeneic Mesenchymal Stem Cells to Baboons , 2006, Cell transplantation.

[17]  M. Kay,et al.  Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells. , 2006, Blood.

[18]  J. Gimble,et al.  The Immunogenicity of Human Adipose‐Derived Cells: Temporal Changes In Vitro , 2006, Stem cells.

[19]  M. Chopp,et al.  Allogeneic bone marrow stromal cells promote glial–axonal remodeling without immunologic sensitization after stroke in rats , 2006, Experimental Neurology.

[20]  L. Lejeune,et al.  Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. , 2005, Blood.

[21]  G. Mancardi,et al.  Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. , 2005, Blood.

[22]  R. Kloner,et al.  Allogeneic Mesenchymal Stem Cell Transplantation in Postinfarcted Rat Myocardium: Short- and Long-Term Effects , 2005, Circulation.

[23]  L. Pénicaud,et al.  Immunomodulatory effect of human adipose tissue‐derived adult stem cells: comparison with bone marrow mesenchymal stem cells , 2005, British journal of haematology.

[24]  J. Mosca,et al.  T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. , 2005, Journal of biomedical science.

[25]  Shu-Ching Hsu,et al.  Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  C. Cobbs,et al.  Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. , 2003, Blood.

[27]  E. Guinan,et al.  Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation , 2003, Transplantation.

[28]  O. Ringdén,et al.  Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex , 2003, Scandinavian journal of immunology.

[29]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.